Comparison of the effects of bitter melon (Momordica charantia) and gotu kola (centella asiatica) extracts on healing of open wounds in rabbits
Bu çalışmanın amacı; tavşanlarda açık yara iyileşmesinde topikal Momordica charantianın (MC) yağlı homojenize formu ve toz formları ile Centella asiatica (CA) ekstratının pomat formunun etkilerini araştırmak, saf zeytinyağı uygulanan ve sağaltım uygulanmayan kontrol grubu ile karşılaştırmaktı. Bu çalışmada kullanılan otuz adet Yeni Zelanda tavşanı 5 gruba ayrıldı: MCnın yağlı homojenize formu, MCnın toz formu, CAnın titre edilmiş ekstratının pomat formu (Madécassol® pomat), kontrol ve saf zeytinyağı. Her bir tavşanda dorsal orta hattın sağ tarafında tam kalınlıkta deriyi kapsayan birer yara (5x5 cm) oluşturuldu ve yukarıda belirtilen ekstratlarla tedavi uygulandı. Yaralar günlük olarak izlendi ve 0, 7, 14, 21 ve 28. günlerde iyileşmemiş yara alanı ve total yara iyileşme yüzdesini ölçmek için planimetri uygulandı. İlk gözlenebilir granulasyon dokusu için ortalama zaman; tüm deney gruplarında kontrol grubundan daha kısa bulundu (P
Tavşanlarda kudret narı (Momordica charantia) ve gotu kola (Centella asiatica) ekstraktlarının açık yara iyileşmesi üzerine etkilerinin karşılaştırılması
This study investigated the eff ects of topically applied oily homogenized and powder forms of bitter melon (Momordica charantia) (MC) and ointment formulation of gotu kola (Centella asiatica) (CA) extract and compared the results with untreated control and pure olive oil groups on wound healing in rabbits. A total of 30 New Zealand rabbits were divided into five equal groups (oily homogenized form of MC, powder form of MC, ointment of CA, control, pure olive oil). Full-thickness 5x5 cm skin wounds were created on the right mid-dorsum area and experimental groups were treated daily with the above mentioned extracts. Wounds were observed daily. Planimetry was performed for the unhealed wound area and the percentage of total wound healing on days 0, 7, 14, 21 and 28. Median time for the first observable granulation tissue was shorter in all experimental groups than in the control group (P<0.05). Filling of the open wound to skin level with granulation tissue was faster in the oily homogenized form of MC and ointment of titrated extract of CA groups (P<0.05). The average time for healing was shorter in the oily homogenized form of MC and ointment of titrated extract of CA groups than in other groups (P<0.05). The results demonstrate that topical application of the oily form of MC and ointment form of CA results in significant improvements on wound healing in rabbits.
___
- 1. Grover JK, Yadav SP: Pharmacological actions and potential uses of Momordica charantia: A review. J Ethnopharmacol, 93, 123-132, 2004.
- 2. Giron LM, Freire V, Alonzo A, Caceres A: Ethnobotanical survey of the medicinal flora used by the Caribs of Guatemala. J Ethnopharmacol, 34, 173- 187, 1991.
- 3. Lans C, Brown G: Observations on ethnoveterinary medicines in Trinidad and Tobago. Prev Vet Med, 35, 125-142, 1998.
- 4. Sofowora EA: Momordica charantia. In, Medicinal Plants and Traditional Medicine in Africa. pp. 209-213, Oxford: John Wiley & Sons Ltd, 1982.
- 5. Barbieri L, Zamboni M, Lorenzoni Montareno L, Sparti S, Stripe F: Inhibition of protein synthesis in vitro by proteins from the seed of Momordica charantia (Bitter pear melon). Biochem J, 186, 443-452, 1980.
- 6. Ng TB, Wong CM, Li WW, Yeung HW: Peptides with antilipolytic and lipogenic activities from seeds of the bitter gourd Momordica charantia (family cucurbitaceae). Gen Pharmacol, 18, 275-281, 1987.
- 7. Biswas AR, Ramaswamy S, Bapna JS: Analgesic eff ect of Momordica charantia seed extract in mice and rats. J Ethnopharmacol, 31, 115-118, 991.
- 8. Ng TB, Tam PP, Hon WK, Choi HL, Yeung HW: Eff ects of momorcharins on ovarian response to gonadotropin-induced superovulation in mice. Int J Fertil, 33, 123-128, 1988.
- 9. Lee-Huang S, Huang PL, Huang PL, Bourinbaiar AS, Chen HC, Kung HF: Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31. Proc Natl Acad Sci USA, 92, 8818-8822, 1995.
- 10. Porro G, Lento P, Marcucci F, Gromo G, Modena D: Diff erent cytotoxic activity and intracellular fate of an anti-CD5-momordin immunotoxin in normal compared to tumor cells. Cancer Immunol Immunother, 40, 213-218, 1995.
- 11. Shabib BA, Khan LA, Rahman R: Hypoglycaemic activity of Coccinia indica and Momordica charantia in diabetic rats: Depression of the hepatic gluconeogenic enzymes glucose-6-phosphatase and fructose-1,6 biphosphatase and elevation of both liver and red-cell shunt enzyme glucose-6-phosphate dehydrogenase. Biochem J, 292, 267-270, 1993.
- 12. Guevara AP, Lim-Sylianco C, Dayrit F, Finch P: Antimutagens from Momordica charantia. Mutat Res, 230, 121-126, 1990.
- 13. Ng TB, Chan WY, Yeung HW: Proteins with abortifacient, ribosome inactivating, immunomodulatory, antitumor and anti-AIDS activities from Cucurbitaceae plants. Gen Pharmacol, 23, 579-590, 1992.
- 14. Raman A, Lau C: Anti-diabetic properties and phytochemistry of Momordica charantia L. Phytomedicine, 2, 349-362, 1996.
- 15. Başaran AA, Ceritoğlu I, Undeğer U, Başaran N: Immunomodulatory activities of some Turkish medicinal plants. Phytother Res, 11, 609-611, 1997.
- 16. Basch E, Gabardi S, Ulbricht C: Bitter melon (Momordica charantia): A review of efficacy and safety. Am J Health Syst Pharmacol, 65, 356-359, 2003.
- 17. Gürbüz İ, Akyüz Ç, Yeşilada E, Şener B: Anti-ulcerogenic effect of Momordica charantia L. fruits on various ulcer models in rats. J Ethnopharmacol, 71, 77-82, 2000.
- 18. Baytop T: Türkiyede Bitkiler ile Tedavi. İstanbul Üniversitesi Yayınları, 1978.
- 19. Yeşilada E, Sezik E, Honda G, Takaishi Y, Takeda Y, Tanaka T: Traditional medicine in Turkey IX: Folk medicine in north-west Anatolia. J Ethnopharmacol, 64, 199-206, 1999.
- 20. Baytop T: Phytotherapy in Turkey: Past and Present. İstanbul University Publications, 1984.
- 21. Brinkhaus B: Centella asiatica in traditional and modern phytomedicine - a pharmacological and clinical profile - Part I: Botany chemistry preparations. Perfusion, 11, 466-474, 1998.
- 22. Srivastava R, Shukla YN, Kumar S: Chemistry and pharmacology of Centella asiatica: A review. J Med Arom Plant Sci, 19, 1049-1056, 1997.
- 23. Brinkhaus B: Centella asiatica in traditional and modern phytomedicine - a pharmacological and clinical profile - Part II: Pharmacological and therapeutic profile, conclusions. Perfusion, 11, 508-520, 1998.
- 24. Maquart FX, Bellon G, Gillery P, Wegrowski Y: Stimulation of collagen synthesis in fibroblast cultures by a triterpene extracted from Centella asiatica. Connect Tissue Res, 24, 107-120, 1990.
- 25. Lubadie RP: An ethnopharmacognostic approach to the search for immunomodulators of plant origin. Planta Med, 55, 339-348, 1989.
- 26. Maquart FX, Chastang F, Simeon A, Birembaut P, Gillery P, Wegrowski Y: Triterpenes from Centella asiatica stimulate extracellular matrix accumulation in rat experimental wounds. Eur J Dermatol, 9, 289- 296, 1999.
- 27. Hong SS, Kim JH, Li H, Shim CK: Advanced formulation and pharmacological activity of hydrogel of the titrated extract of Centella asiatica. Arch Pharm Res, 28, 502-508, 2005.
- 28. Shukla A, Rasik AM, Jain GK, Shankar R, Kulashrestha DK, Dhawan BN: In vitro and in vivo wound healing activity of asiaticoside isolated from Centella asiatica. J Ethnopharmacol, 65, 1-11, 1999.
- 29. Poizot A, Dumez D: Modification of the kinetics of healing after iterative exersis in the rat. Action of a triterpenoid and its derivatives on the duration of healing. C R Acad Sci Hebd Seances Acad Sci D, 286, 789-792, 1978.
- 30. Swaim SF, Bradley DM, Spano JS, McGuire JA, Hoff man CE, Trachy RE: Evaluation of multipeptide copper complex medication on open wound healing in dogs. J Am Anim Hosp Assoc, 29, 519-527, 1993.
- 31. Evans P: The healing process at cellular level: A review. Physiotheraphy, 66, 256-259, 1980.
- 32. Pierce GF, Mustoe TA: Pharmacologic enhancement of wound healing. Annu Rev Med, 46, 467-481, 1995.
- 33. Uluışık D, Keskin E: The eff ects of Ginseng and Echinacea on some plasma cytokine levels in rats. Kafkas Univ Vet Fak Derg, 18 (1): 65-68, 2012.
- 34. Prasad V, Jain V, Girish D, Dorle AK: Wound-healing property of Momordica charantia L. fruit powder. J Herb Pharmacother, 6, 105-115, 2006.
- 35. Sharma S, Sharma MC, Kohli DV: Wound healing activity of the etherchloroform extract of Momordica charantia fruits in rats. Digest J Nanomater Biostructures, 5, 123-126, 2010.
- 36. Teoh SL, Latiff AA, Das S: The eff ect of topical extract of Momordica charantia (bitter gourd) on wound healing in nondiabetic rats and in rats with diabetes induced by streptozotocin. Clin Exp Dermatol, 34 (7): 815-822, 2009.
- 37. Ono T, Tsuji T, Sakai M, Yukizaki C, Ino H, Akagi I, Hiramatsu K, Matsumoto Y, Sugiura Y, Uto H, Tsubouchi H, Gohda E: Induction of hepatocyte growth factor production in human dermal fibroblasts and their proliferation by the extract of bitter melon pulp. Cytokine, 46 (1): 119- 126, 2009.
- 38. Winter GD: A note on wound healing under dressings with special reference to perforated-film dressings. J Invest Dermatol, 45, 299-302, 1965.